A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

The presidential fitness test, a divisive hallmark of children’s education from the 1960s to the 2010s, is back as part of ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...